Reviewed by the Help Dementia Editorial Team — our editors review every article for accuracy against guidance from the National Institute on Aging, the Alzheimer’s Association, and peer-reviewed sources.
Some medication sits at the center of this dementia and brain health question.
Yes, medication side effects can absolutely be mistaken for new mental health problems—and this happens far more often than many people realize. When you start taking a new medication, whether it’s a steroid for inflammation, an antihypertensive for blood pressure, or an antipsychotic for another condition, your brain chemistry shifts. Sometimes those shifts create symptoms that look identical to depression, anxiety, psychosis, or mood changes you might attribute to a new mental illness rather than the drug itself. The challenge is significant: there are no specific laboratory tests that can definitively differentiate between medication-induced psychiatric symptoms and primary mental illness.
A person could develop severe depression, psychosis, or anxiety within days or weeks of starting a new medication, and both the patient and their doctor might conclude they’ve developed a new psychiatric condition—when actually, the medication is the culprit. The consequences of this diagnostic confusion can be serious. Misdiagnosis of medication-induced psychiatric disorders is common and can lead to unnecessary treatment, prolonged hospitalization, increased healthcare costs, treatment delays, and even unintended harmful interventions. A patient might end up on additional psychiatric medications to treat symptoms that would resolve simply by stopping or adjusting the original drug. For someone already managing dementia or cognitive decline, the stakes are even higher: adding unnecessary psychiatric medications increases fall risk, cognitive impairment, and overall burden on an already vulnerable system.
Table of Contents
- Can Medication Side Effects Really Mimic Mental Health Problems?
- Which Medications Are Most Likely to Cause Psychiatric Side Effects?
- Who Is at Highest Risk for Medication-Induced Psychiatric Problems?
- How Can Doctors Tell the Difference Between Medication Effects and Primary Mental Illness?
- Why Misdiagnosis Happens and What It Costs
- Current Prescription Trends and How They Increase Risk
- What Experts and Regulators Are Doing to Prevent Misdiagnosis
- Conclusion
Can Medication Side Effects Really Mimic Mental Health Problems?
The short answer is yes, and the clinical literature on this is substantial. many medications can trigger authentic psychiatric symptoms that are neurochemically distinct from primary mental illness, yet clinically indistinguishable without careful investigation. The problem is that psychiatric symptoms—depression, anxiety, hallucinations, mood changes—don’t come with a label telling you their origin. Your brain experiences the same neurological cascade whether the depressive symptoms stem from medication-induced changes in serotonin levels or from major depressive disorder. This neurochemical overlap is exactly why misdiagnosis happens. Consider someone with rheumatoid arthritis who starts taking corticosteroids to manage inflammation.
Within two weeks, they develop severe depression, mood swings, and anxiety. Their rheumatologist may attribute these to stress related to their diagnosis. Their primary care doctor might recommend a psychiatry referral. The psychiatrist, seeing depression and anxiety, may diagnose major depressive disorder or generalized anxiety disorder and recommend antidepressants. Meanwhile, the steroid-induced psychiatric effects could resolve entirely once the steroid dose is reduced or stopped. Instead, the patient is now on psychiatric medications they may not need, experiencing additional side effects, and potentially facing years of unnecessary mental health treatment.
Which Medications Are Most Likely to Cause Psychiatric Side Effects?
Several medication classes are well-established culprits for medication-induced psychiatric symptoms. Corticosteroids—commonly prescribed for autoimmune conditions, asthma, and severe inflammation—are particularly notorious. These drugs reduce serotonin levels, which can trigger depression. They also modulate dopamine pathways, increasing the risk of psychosis and mood swings, and elevate glutamate levels, heightening anxiety. Steroid-induced psychosis typically develops shortly after beginning the medication and can include mania, depression, and anxiety. A person on high-dose steroids for lupus or vasculitis might suddenly experience paranoia or hallucinations within days of starting treatment—symptoms their doctor might initially attribute to the stress of illness rather than the medication itself. Antipsychotics themselves, despite being prescribed to treat psychosis, can paradoxically cause depression, sedation, weight gain, and other psychiatric effects in some patients.
Beta-blockers, prescribed for hypertension and heart conditions, show a more complex picture. A large population study of 1.4 million Swedish individuals revealed mixed results: while some patients showed reduced hospitalizations for depressive disorders, the long-term improvement in anxiety treatment was limited. This mixed evidence illustrates an important point: medication effects aren’t uniform. The same drug can help one person and harm another, and predicting who will experience psychiatric side effects is difficult. SSRIs now account for nearly half of all antidepressant prescriptions, making them ubiquitous in modern medicine. Yet SSRIs themselves can occasionally trigger or worsen anxiety, suicidality, or emotional blunting—effects that might be mistaken for treatment-resistant depression or a worsening of the original condition. The complexity here is that distinguishing between a medication’s intended therapeutic effect and an unwanted psychiatric side effect sometimes requires stopping the medication and observing what happens—a challenging proposition when you’re treating a serious condition.
Who Is at Highest Risk for Medication-Induced Psychiatric Problems?
Not everyone who takes a medication experiences psychiatric side effects, but certain risk factors significantly increase the likelihood. High dosages of medications are a major risk factor—taking more of a drug means more neurochemical disruption. Polypharmacy, or taking multiple medications simultaneously, dramatically increases risk because drugs can interact in unpredictable ways, compounding psychiatric effects. Patients at the extremes of age—very young children and older adults—are more vulnerable because their metabolism and blood-brain barrier function differ from younger adults.
People with a prior history of mental illness are at elevated risk, as their brain chemistry may be more sensitive to medication-induced disruption. A person with a history of depression who starts corticosteroids is more likely to experience steroid-induced depression than someone with no psychiatric history. Critical illness or hospitalization itself increases risk, both because seriously ill patients typically receive more medications and because the stress of illness creates a neurobiological environment more prone to psychiatric effects. For someone with dementia or cognitive decline, this becomes especially concerning: medication-induced psychiatric symptoms—hallucinations, agitation, mood changes—can be catastrophically difficult to distinguish from dementia progression itself.
How Can Doctors Tell the Difference Between Medication Effects and Primary Mental Illness?
The diagnostic approach hinges on temporal relationships and pharmacological plausibility. The most reliable method is the “challenge, de-challenge, and re-challenge” approach: stopping the suspected medication to see if psychiatric symptoms resolve, and sometimes restarting it to confirm they return. This approach directly establishes whether the medication is causing the symptoms. If a person’s psychotic symptoms resolve within days or weeks after stopping a steroid, that’s powerful evidence the steroid caused the psychosis. If restarting the steroid triggers the symptoms again, the diagnosis is nearly certain.
Beyond this observational approach, clinicians use the Naranjo scale, a validated 10-item tool with good reliability for predicting the probability of adverse drug reactions. It assesses the temporal relationship between drug exposure and psychiatric effect, whether the symptoms fit known pharmacological mechanisms of the drug, and other factors. The key limitation is that this tool requires clinical judgment and knowledge—a busy primary care doctor with limited psychiatric expertise might not know that a particular medication commonly causes psychiatric effects, leading to misattribution of symptoms to primary mental illness. The challenge is that true causality can only be established through careful observation over time, not through a quick lab test or imaging study. This means misdiagnosis often occurs in rushed clinical settings where there isn’t time for careful drug-by-drug analysis, or where the connection between a medication started months earlier and new psychiatric symptoms isn’t made. A person prescribed blood pressure medication in January might develop depression in March; by the time they see a psychiatrist in May, the temporal connection seems distant, and the psychiatrist may not think to ask about medications started four months earlier.
Why Misdiagnosis Happens and What It Costs
Misdiagnosis of medication-induced psychiatric disorders is common, partly because psychiatric symptoms are genuinely difficult to attribute to their source. A person with depression looks and feels the same whether the depression is primary or medication-induced, so without a systematic approach to medication review, the diagnosis defaults to the most obvious explanation: the person has developed a mental illness. This cognitive shortcut, while understandable, can be harmful. The costs of misdiagnosis are substantial and multifaceted. Unnecessary psychiatric medications add their own side effects to an already complicated medication regimen.
A person misdiagnosed with depression and started on an SSRI, when actually their depression was steroid-induced, now takes a medication they don’t need, experiencing potential sexual dysfunction, weight changes, and other SSRI side effects. Treatment delays occur when patients receive psychiatric medication instead of dose adjustment or discontinuation of the offending drug. Prolonged hospitalization can result when a psychiatric diagnosis leads to inpatient psychiatric admission rather than addressing the medication-induced cause. Healthcare costs skyrocket with unnecessary specialist visits, psychiatric medications, and extended hospitalization. For older adults and those with dementia, the harm is compounded: additional medications increase fall risk, cognitive impairment, and interaction with other drugs managing underlying conditions.
Current Prescription Trends and How They Increase Risk
The landscape of psychiatric medication prescribing has shifted significantly. Among Americans seeking mental health treatment, 16.5% of adults take prescription psychiatric medication. SSRIs account for nearly half of all antidepressant prescriptions, which is medically reasonable but also means a large population is exposed to SSRI-related psychiatric effects like anxiety or emotional blunting. Anxiety medication prescriptions—including benzodiazepines—actually declined from 2.7% of all prescriptions in 2018 to 2.2% in 2024, reflecting appropriate efforts to reduce benzodiazepine use.
The concerning trend is that while psychiatric medication use is well-established, recognition of medication-induced psychiatric effects hasn’t necessarily kept pace with prescribing rates. A study from December 2025 published in the Journal of the American Academy of Child & Adolescent Psychiatry found that 1 in 4 young people taking psychotropic drugs are using dangerous medication combinations—polypharmacy without adequate monitoring for psychiatric side effects. Beyond psychiatric medications, antipsychotic-induced extrapyramidal side effects (movement disorders) range from 9-63.7% across countries, with significant variation based on medication type, dose, and population. This enormous range illustrates how difficult it is to predict who will experience medication-induced problems, and how prevalent they truly are.
What Experts and Regulators Are Doing to Prevent Misdiagnosis
The FDA and psychiatric organizations are increasingly emphasizing enhanced pharmacovigilance—systematic monitoring of which medications trigger psychiatric disorders, particularly in vulnerable populations like children and adolescents. This represents a shift toward more proactive identification of medication-induced psychiatric problems rather than waiting for misdiagnosis to occur. Recent expert attention has focused on building better tools and protocols for clinicians to systematically evaluate whether new psychiatric symptoms might be medication-induced.
Despite these efforts, the infrastructure for identifying and preventing misdiagnosis remains incomplete. Many primary care doctors and even some psychiatrists lack systematic approaches to evaluating medication-induced psychiatric effects. Patients often don’t know to ask whether a new symptom could be from their medication. The result is that while the research is increasingly clear about which drugs cause psychiatric problems, clinical practice hasn’t fully caught up to implement these findings in routine care.
Conclusion
Medication-induced psychiatric side effects are real, common, and frequently mistaken for primary mental illness. Without specific laboratory tests to differentiate the two, misdiagnosis is predictable and happens regularly, with serious consequences including unnecessary psychiatric treatment, prolonged hospitalization, and increased healthcare costs. The key to avoiding this trap is systematic medication review whenever new psychiatric symptoms appear—asking not just “what mental illness could this be?” but “could this medication be causing this?” If you or a loved one develops new psychiatric symptoms, particularly depression, anxiety, or mood changes, work with your doctor to carefully review all current medications, their dosages, when they were started, and their known psychiatric side effects.
The temporal relationship between medication changes and symptom onset is crucial. For those managing dementia or cognitive decline, this becomes even more critical: medication-induced psychiatric effects can accelerate apparent cognitive decline and lead to unnecessary psychiatric medications that worsen cognition. Ask your doctor specifically whether your symptoms fit the pattern of medication-induced effects, request a trial of dose reduction or medication discontinuation if appropriate, and if symptoms resolve, that’s your answer.
You Might Also Like
- Why So Many People Are Suddenly Questioning Long-Term Psychiatric Medication Use
- What Doctors Mean When They Say a Medication Is Safe Long Term
- whole grains Consumption After Age 70 Tied to Faster Brain Aging
For more, see CDC — Alzheimer’s and Dementia.
